PharmaMar’s lurbinectedin granted orphan drug designation by FDA for small cell lung cancer treatment

Spanish pharmaceutical company PharmaMar has announced that its cancer drug, lurbinectedin, has received orphan drug designation from the US Food and Drug Administration (FDA) for ... Read More